FindTrial
Sign In

A comparative study in Homoeopathy for hypertension

Comparative effectiveness of Homoeopathic similimum vis-a-vis Allium sativum Q in management of essential Hypertension:A randomised clinical trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/04/042148
Enrollment
60
Registered
2022-04-26
Start date
Unknown
Completion date
Unknown
Last updated
2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I10- Essential (primary) hypertension

Interventions

Intervention1: Homoeopathic similimum medicine: Homoeopathic similimum medicine in potency as required based on homoeopathic principles as per Organon of Medicine, Homoeopathic similimum medicine take

Sponsors

Dr Hema
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Diagnosed cases of essential hypertension Cases presenting with signs/symptoms of Essential Hypertension with raised blood pressure levels Cases that give consent and are willing for regular follow-ups

Exclusion criteria

Exclusion criteria: Hypertension cases associated with complications like kidney diseases, heart diseases, stroke, etc, and severe concurrent illness Cases with autoimmune disorders Pregnant females Immunocompromised individuals Cases with substance abuse and/or dependence

Design outcomes

Primary

MeasureTime frame
Systolic and Diastolic blood pressure levelsTimepoint: Initially at baseline then at every 15 days upto 1 year—

Secondary

MeasureTime frame
SF36 QuestionnaireTimepoint: Initially at baseline then at the end of 1 year—

Countries

India

Contacts

Public ContactDr Hema

Nehru Homoeopathic Medical College and Hospital

drannapurna.sarangi@gmail.com7982775800

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026